The Clareon family of IOLs is now available in the U.S., with an international rollout set to take place throughout 2022 and 2023, according to an Alcon press release.
“This is really an extremely exciting day for us as we finally get to share the news that our latest advancement in IOL technology, Clareon, will now be available to cataract surgeons and their patients in the U.S.,” Jim Di Filippo, vice president and general manager, U.S. Surgical at Alcon, said in a webinar hosted by the company.
The portfolio of (Read more...)